[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fbGRmC8RgJis673cdraqyewKyfWGz3MzzcdWQimBVqA0":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":36,"rows":43},"Linkoeping University",[4],190,false,48,2,2019217,0,185,[14,17,20,23,25,27,30,33],{"name":15,"count":16},"Depression",13,{"name":18,"count":19},"Anxiety",8,{"name":21,"count":22},"Depressive Symptoms",6,{"name":24,"count":22},"Chronic Pain",{"name":26,"count":22},"Anxiety Disorders",{"name":28,"count":29},"Frailty",5,{"name":31,"count":32},"Cancer",4,{"name":34,"count":32},"Heart Failure",[],[37,38,39,40,41,42],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[44,71,95,121,150],{"intervention":45,"totalTrials":46,"cells":47},"Sodium Chloride",1,{"EARLY_PHASE1":48,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":56,"NA":69},{"trials":49,"activeCount":11},[],{"trials":51,"activeCount":11},[],{"trials":53,"activeCount":11},[],{"trials":55,"activeCount":11},[],{"trials":57,"activeCount":11},[58],{"nctId":59,"briefTitle":60,"status":61,"phases":62,"primaryCompletion":63,"completion":63,"start":64,"enrollment":65,"conditions":66,"interventions":68},"NCT06114459","Impact of Postoperative Skin Disinfection With Chlorhexidine on Bacterial Colonization","COMPLETED",[41],"2023-03-20","2019-08-10",60,[67],"Surgical Site Infection",[45],{"trials":70,"activeCount":11},[],{"intervention":72,"totalTrials":46,"cells":73},"GAD-alum (Diamyd) 40 μg\u002FmL",{"EARLY_PHASE1":74,"PHASE1":76,"PHASE2":78,"PHASE3":89,"PHASE4":91,"NA":93},{"trials":75,"activeCount":11},[],{"trials":77,"activeCount":11},[],{"trials":79,"activeCount":11},[80],{"nctId":81,"briefTitle":82,"status":61,"phases":83,"primaryCompletion":84,"completion":84,"start":85,"enrollment":22,"conditions":86,"interventions":88},"NCT05351879","Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes",[38,39],"2023-08-29","2022-05-09",[87],"Diabetes Mellitus, Type 1",[72],{"trials":90,"activeCount":11},[],{"trials":92,"activeCount":11},[],{"trials":94,"activeCount":11},[],{"intervention":96,"totalTrials":46,"cells":97},"Albendazole",{"EARLY_PHASE1":98,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":108},{"trials":99,"activeCount":11},[],{"trials":101,"activeCount":11},[],{"trials":103,"activeCount":11},[],{"trials":105,"activeCount":11},[],{"trials":107,"activeCount":11},[],{"trials":109,"activeCount":11},[110],{"nctId":111,"briefTitle":112,"status":61,"phases":113,"primaryCompletion":114,"completion":115,"start":116,"enrollment":117,"conditions":118,"interventions":120},"NCT00857116","Deworming Against Tuberculosis",[42],"2013-06","2013-08","2009-03",140,[119],"Tuberculosis",[96],{"intervention":122,"totalTrials":46,"cells":123},"Doxycycline",{"EARLY_PHASE1":124,"PHASE1":126,"PHASE2":128,"PHASE3":130,"PHASE4":132,"NA":134},{"trials":125,"activeCount":11},[],{"trials":127,"activeCount":11},[],{"trials":129,"activeCount":11},[],{"trials":131,"activeCount":11},[],{"trials":133,"activeCount":11},[],{"trials":135,"activeCount":11},[136],{"nctId":137,"briefTitle":138,"status":61,"phases":139,"primaryCompletion":140,"completion":140,"start":141,"enrollment":142,"conditions":143,"interventions":149},"NCT01205464","Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosis",[42],"2008-02","2005-02",15,[144,145,146,147,148],"Fatigue","Radicular Pain","Cognitive Dysfunction","Paresthesia","Paresis",[122],{"intervention":151,"totalTrials":46,"cells":152},"sertraline, mirtazapine, venlafaxine, citalopram, escitalopram",{"EARLY_PHASE1":153,"PHASE1":155,"PHASE2":157,"PHASE3":159,"PHASE4":161,"NA":163},{"trials":154,"activeCount":11},[],{"trials":156,"activeCount":11},[],{"trials":158,"activeCount":11},[],{"trials":160,"activeCount":11},[],{"trials":162,"activeCount":11},[],{"trials":164,"activeCount":11},[165],{"nctId":166,"briefTitle":167,"status":61,"phases":168,"primaryCompletion":169,"completion":169,"start":170,"enrollment":171,"conditions":172,"interventions":176},"NCT04806230","Serum Concentrations of Antidepressant Drugs in Pregnant Women - a Naturalistic Study",[],"2013-09-30","2011-04-01",81,[173,174,175],"Pharmacokinetics","Antidepressive Agents","Pregnancy",[151]]